Prime Standard Segment announced today that its research and diagnostic antibodies unit AbD Serotec has signed a license agreement with VU University Medical Center (VUmc), which provides AbD Serotec with worldwide exclusive rights to commercialize a number of antibody clones for research applications. These include the world's most widely used reagents for studying macrophage subsets in rats, the "ED series" of antibodies.
Showing posts with label HuCAL. Show all posts
Showing posts with label HuCAL. Show all posts
Thursday, 16 September 2010
Subscribe to:
Posts (Atom)